Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Jane P. Matthews"'
Autor:
E Abdi, Peter Browett, Janey M. Stone, Anthony Bonaventura, Jane P. Matthews, Ming-Celine Dubosq, Michael R. Green, Noemi Horvath, David Ellis, Paula Marlton, Max Wolf, Andrew Grigg, Henry Januszewicz, Paul Cannell, Warwick Benson, Mark Hertzberg
Publikováno v:
American Journal of Hematology. 89:536-541
Increasing dose intensity (DI) of chemotherapy for patients with aggressive non-Hodgkin lymphoma (NHL) may improve outcomes at the cost of increased toxicity. This issue was addressed in a randomized trial aiming to double the DI of myelosuppressive
Autor:
Juliana Di Iulio, Jane P. Matthews, John V. Reynolds, Arumugam Manoharan, Surender Juneja, Michael F. Leahy, Heather Baxter
Publikováno v:
Drugs & Aging. 24:481-488
To evaluate the efficacy of a flexible low-intensity combination chemotherapy (FLICC) protocol in a multicentre, phase II study of elderly patients with acute myeloid leukaemia (AML).Twenty-five patients aged 61-78 years (median 70 years) with de nov
Autor:
Jane P. Matthews, John F. Seymour, Janine Campbell, Surender Juneja, Max Wolf, Janey M. Stone
Publikováno v:
European Journal of Haematology. 76:473-480
Background: The prognostic significance of marrow involvement in diffuse large cell lymphoma (DLCL) is controversial. Factors that that have been reported to influence prognosis include the pattern and extent of marrow infiltration and histological d
Autor:
Jane P. Matthews, Michael P. Mac Manus, Danny Rischin, Andrew Wirth, David Ball, Rodney J. Hicks
Publikováno v:
Lung Cancer. 49:95-108
Summary Background: We previously reported that F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) response correlated strongly with survival after radical radiotherapy (RT)/chemoradiotherapy for non-small cell lung cancer (NSCLC). PET-
Autor:
Michael F. Leahy, Max Wolf, Carla I. Falkson, Henry Januszewicz, K Richards, John F. Seymour, Henry Miles Prince, B Dale, E Abdi, James J. Biagi, Kirsten Herbert, Jane P. Matthews, Corey Smith
Publikováno v:
Leukemia & Lymphoma. 46:197-206
The 4-day combination of dexamethasone, ifosfamide, cisplatin, and etoposide (DICE) is a salvage regimen for lymphoma. We report a prospective phase II multi-center trial of a modified DICE regimen in relapsed or refractory Hodgkin (HL) or non-Hodgki
Autor:
Jane P. Matthews, Lester J. Peters, Rodney J. Hicks, Annette Hogg, David Binns, Danny Rischin, David Ball, Michael P. Mac Manus
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 60:412-418
Purpose To investigate the relationship between positron emission tomography (PET) detected inflammatory changes in irradiated normal tissues and metabolic response at tumor sites in patients receiving radical radiotherapy for non–small-cell lung c
Autor:
Max Wolf, Andrew Grigg, EH Januszewicz, Jane P. Matthews, John F. Seymour, Henry Miles Prince, Sue Morgan
Publikováno v:
Leukemia. 18:1034-1038
Predictive factors for successful stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine
Autor:
Sandro V. Porceddu, Annette Hogg, Jane P. Matthews, Danny Rischin, Lester J. Peters, Robert E. Ware, June Corry, Rodney J. Hicks
Publikováno v:
Head & Neck. 26:1008-1017
Background. Residual structural abnormalities af- ter definitive treatment of head and neck squamous cell car- cinoma (HNSCC) are common and pose difficult management problems. The usefulness of fluorine-18 fluorodeoxyglucose positron emission tomogr
Publikováno v:
Annals of Oncology. 14:273-276
Background: The National Cancer Institute has recommended a bone marrow biopsy length of ≥20 mm for the staging and surveillance of patients with non-Hodgkin's lymphoma. However, there are few published data to support this recommendation, particul
Publikováno v:
European Journal of Cancer Care. 11:245-253
The objective of the study was to evaluate the acceptability and feasibility of computer touch-screen technology as a method for patients to report psychosocial functioning in an ambulatory cancer clinic. Patients participating in a randomized trial